License Agreements
9,272 Contracts & Agreements
License agreements define rights and other benefits for the licensing of intellectual property.
Browse License Agreements by Industry
- Aerospace & Defense (20 contracts from 8 companies)
- Air Freight & Logistics (7 | 3)
- Airlines (4 | 2)
- Auto Components (9 | 8)
- Automobiles (7 | 5)
- Banks (10 | 8)
- Beverages (11 | 3)
- Biotechnology (2,832 | 515)
- Building Products (8 | 5)
- Capital Markets (185 | 18)
- Chemicals (57 | 23)
- Commercial Services & Supplies (39 | 18)
- Communications Equipment (19 | 14)
- Construction & Engineering (7 | 2)
- Consumer Finance (8 | 6)
- Containers & Packaging (7 | 2)
- Distributors (3 | 2)
- Diversified Consumer Services (24 | 6)
- Diversified Financial Services (8 | 6)
- Diversified Telecommunication Services (8 | 6)
- Electric Utilities (10 | 5)
- Electrical Equipment (32 | 12)
- Electronic Equipment, Instruments & Components (41 | 18)
- Energy Equipment & Services (72 | 38)
- Entertainment (68 | 13)
- Equity Real Estate Investment Trusts (REITs) (12 | 7)
- ETFs (83 | 47)
- Food Products (47 | 20)
- Food & Staples Retailing (5 | 3)
- Gas Utilities (1 | 1)
- Health Care Equipment & Supplies (624 | 171)
- Health Care Providers & Services (208 | 76)
- Health Care Technology (28 | 16)
- Hotels, Restaurants & Leisure (73 | 33)
- Household Durables (35 | 12)
- Household Products (1 | 1)
- Independent Power & Renewable Electricity Producers (1 | 1)
- Industrial Conglomerates (2 | 1)
- Insurance (8 | 8)
- Interactive Media & Services (27 | 16)
- Internet & Direct Marketing Retail (16 | 10)
- IT Services (36 | 15)
- Leisure Products (11 | 7)
- Life Sciences Tools & Services (157 | 26)
- Machinery (12 | 8)
- Media (66 | 17)
- Metals & Mining (40 | 17)
- Multiline Retail (1 | 1)
- Oil, Gas & Consumable Fuels (81 | 31)
- Paper & Forest Products (4 | 1)
- Personal Products (59 | 24)
- Pharmaceuticals (1,191 | 268)
- Professional Services (16 | 10)
- Real Estate Management & Development (4 | 3)
- Semiconductors & Semiconductor Equipment (91 | 34)
- Software (192 | 57)
- SPACs, Investment, & Acquisition Companies (109 | 41)
- Specialty Retail (14 | 9)
- Technology Hardware, Storage & Peripherals (26 | 10)
- Textiles, Apparel & Luxury Goods (41 | 11)
- Thrifts & Mortgage Finance (2 | 1)
- Tobacco (8 | 2)
- Trading Companies & Distributors (1 | 1)
- Transportation Infrastructure (1 | 1)
- Water Utilities (4 | 3)
- Wireless Telecommunication Services (10 | 4)
- Unassigned Industry (2,428 | 942)
- License Agreement, dated February 3, 2023, by and between the Registrant and Janssen Pharmaceutica NV (Contineum Therapeutics, Inc., Filed With SEC on March 15, 2024)
- Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Coherus BioSciences, Inc., Filed With SEC on March 15, 2024)
- License and Supply Agreement, dated December 11, 2023, between the Registrant and Medica S.p.A. (pursuant to Item 601(b)(2)(ii) of Regulation S-K, certain information contained in... (NEPHROS INC, Filed With SEC on March 15, 2024)
- License Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 22, 2023 (Century Therapeutics, Inc., Filed With SEC on March 14, 2024)
- License and Supply Agreement, dated as of January 16, 2024, by and between UroGen Pharma Ltd. and Medac Gesellschaft fr klinische Spezialprparate m.b.H (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
- License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on March 13, 2024)
- License Agreement, dated as of August 3, 2017, by and between Solid Biosciences, LLC and President and Fellows of Harvard College (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- License Agreement, dated as of June 23, 2016, by and between Solid GT, LLC and President and Fellows of Harvard College (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Life Technologies Cell Line License Agreement, dated as of November 20, 2016, by and between Solid Biosciences, LLC and Life Technologies Corporation (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Patent License Agreement, dated as of March 10, 2016, by and between Solid GT, LLC and the Regents of the University of Michigan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- License Agreement, dated as of October 15, 2015, by and between Solid GT, LLC and The Curators of the University of Missouri (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Exclusive Patent License Agreement, dated as of October 16, 2015, by and between Solid GT, LLC and the University of Washington (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Amendment 2 to Exclusive License Agreement, dated December 20, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Amendment 1 to Exclusive License Agreement, dated July 4, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Exclusive License Agreement, by and between the Registrant and (Entrada Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
- License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
- Third Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC (Lirum Therapeutics, Inc., Filed With SEC on March 11, 2024)
- Second Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC (Lirum Therapeutics, Inc., Filed With SEC on March 11, 2024)
- First Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology (Lirum Therapeutics, Inc., Filed With SEC on March 11, 2024)
- License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC dated January 12 (Lirum Therapeutics, Inc., Filed With SEC on March 11, 2024)
- Second Amendment to License Agreement, dated January 16, 2024, by and between 2seventy bio, Inc. and the National Institutes of Health (2seventy bio, Inc., Filed With SEC on March 7, 2024)
- Amendment No. 1 to the License Agreement for RAF, dated March 4, 2024, by and between Day One Biopharmaceuticals, Inc. and Sunesis Pharmaceuticals, Inc (Day One Biopharmaceuticals Holding Co LLC, Filed With SEC on March 7, 2024)
- License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V. and Symatese Aesthetics S.A.S (Evolus, Inc., Filed With SEC on March 7, 2024)
- Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 7, 2024)
- First Amendment to License and Supply Agreement, dated as of February 26, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 7, 2024)
- License Agreement dated January 12, 2024 by and among Lipocine, Inc., Gordon Silver Limited, and Verity Pharmaceuticals (Lipocine Inc., Filed With SEC on March 7, 2024)
- License Agreement for Space and Services, dated February 8, 2024, by and between Soleno Therapeutics, Inc. and Hudson Towers at Shore Center, LLC (SOLENO THERAPEUTICS INC, Filed With SEC on March 7, 2024)
- License and Development Agreement, dated January 8, 2023, by and between Selecta Biosciences, Inc. and Audentes Therapeutics, Inc (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
- Patent License Agreement by and between Biogen MA, Inc. and Cartesian Therapeutics, Inc., dated September 8, 2023 (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
- Patent License Agreement, between Cartesian Therapeutics, Inc. and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute of the... (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
- Amendment No. 1 to License and Development Agreement, dated as of October 31, 2023, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)
- Second Amendment to the UTRF License Agreement dated March 4, 2024 (GTX INC, Filed With SEC on March 7, 2024)
- Amendment No. 1 to License Agreement for RAF, dated March 4, 2024, by and between the Registrant and Day One Biopharmaceuticals, Inc (SUNESIS PHARMACEUTICALS INC, Filed With SEC on March 7, 2024)
- License Agreement for RAF, dated December 16, 2019, by and between the Registrant and Day One Biopharmaceuticals, Inc (SUNESIS PHARMACEUTICALS INC, Filed With SEC on March 7, 2024)
- License Agreement, dated November 17, 2023, by and between the Registrant and Inhibrx, Inc (Tracon Pharmaceuticals, Inc., Filed With SEC on March 5, 2024)
- License Agreement, dated as of October 4, 2023, by and between Ichnos Sciences SA, Ichnos Sciences Inc. and the Registrant (CATABASIS PHARMACEUTICALS INC, Filed With SEC on March 4, 2024)
- Amendment No. 12 to License Agreement, dated October 2, 2023, between MIL 21E, LLC and the Registrant (Prime Medicine, Inc., Filed With SEC on March 1, 2024)
- Second Amendment to Development and License Agreement dated March 21, 2023, dated as of December 10, 2023, by and between Hangzhou Highlightll Pharmaceutical Co. Ltd. and Biohaven... (Biohaven Ltd., Filed With SEC on February 29, 2024)
- License Agreement, between UL International Singapore Ltd., as Licensor, and ULSE Inc., as Licensee (UL Solutions Inc., Filed With SEC on February 29, 2024)